REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)
Regeneron Pharmaceuticals, Inc.
Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 07/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)
COLOR MARK
NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word COVERED with a stylized "V" with the word REGEN over the letters "COV" in the word COVERED. Below the letters "ERED"
in the word COVERED are the words FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) in a smaller font.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
861 x 347
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Regeneron Pharmaceuticals, Inc.
*MAILING ADDRESS
777 Old Saw Mill River Road
*CITY
Tarrytown
*STATE
(Required for U.S. applicants)
New York
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10591
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
New York
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
035
*IDENTIFICATION
Business administration services, namely, business administration of a program to provide access to pharmaceutical preparations for treatment
or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Business administration services, namely, business administration
of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
036
*IDENTIFICATION
Financial administration services, namely, financial administration of a program to provide access to pharmaceutical preparations for
treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Financial administration services, namely, financial
administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical and pharmaceutical consultation regarding pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease,
and respiratory diseases and disorders
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Terrence J. McAllister
ATTORNEY DOCKET NUMBER
554.1796UST1
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Ohlandt, Greeley, Ruggiero & Perle, LLP
INTERNAL ADDRESS
10th Floor
STREET
One Landmark Square
CITY
Stamford
STATE
Connecticut
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
06901
PHONE
203-327-4500
FAX
203-327-6401
EMAIL ADDRESS
trademark@ogrp.com
OTHER APPOINTED ATTORNEY
Jeffrey J. Scepanski and Charles N.J. Ruggiero
CORRESPONDENCE INFORMATION
NAME
Terrence J. McAllister
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademark@ogrp.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
/OGRP-CNR-TJM-JJS/
SIGNATORY'S NAME
Terrence J. McAllister
SIGNATORY'S POSITION
Attorney of record for Applicant- New York Bar Member
SIGNATORY'S PHONE NUMBER
12033274500
DATE SIGNED
07/15/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 07/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90831614
Filing Date:07/15/2021
To the Commissioner for Trademarks:
MARK: REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) (stylized and/or with design, see mark)
The literal element of the mark consists of REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB). The mark consists of the word COVERED with a stylized "V" with the word REGEN over the letters
"COV" in the word COVERED. Below the letters "ERED" in the word COVERED are the words FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) in a smaller font.
The applicant, Regeneron Pharmaceuticals, Inc., a corporation of New York, having an address of
777 Old Saw Mill River Road
Tarrytown, New York 10591
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 035: Business administration services, namely, business administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19,
coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide
discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 036: Financial administration services, namely, financial administration of a program to provide access to pharmaceutical preparations for treatment or prevention of
COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to
provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical and pharmaceutical consultation regarding pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and
disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Terrence J. McAllister. Other appointed attorneys are Jeffrey J. Scepanski and Charles N.J. Ruggiero. Terrence J. McAllister of Ohlandt,
Greeley, Ruggiero & Perle, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
10th Floor
One Landmark Square
Stamford, Connecticut 06901
United States
203-327-4500(phone)
203-327-6401(fax)
trademark@ogrp.com
The docket/reference number is 554.1796UST1.
Terrence J. McAllister submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Terrence J. McAllister
PRIMARY EMAIL FOR CORRESPONDENCE: trademark@ogrp.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /OGRP-CNR-TJM-JJS/ Date: 07/15/2021
Signatory's Name: Terrence J. McAllister
Signatory's Position: Attorney of record for Applicant- New York Bar Member
Signatory's Phone Number: 12033274500
Signature method: Sent to third party for signature
Payment Sale Number: 90831614
Payment Accounting Date: 07/15/2021
Serial Number: 90831614
Internet Transmission Date: Thu Jul 15 21:27:03 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2021071521270367
4332-90831614-780f6e0ebf1bcef6d47bd43773
9976e653551ecb4d333261e3b86419f7b3be1050
-DA-27033769-20210714231828558638